The Head and Neck Steering Committee (HNSC) addresses the design, prioritization, and evaluation of concepts for phase 2, 2/3, and 3 clinical trials in adult head and neck cancers. Committee activities help foster collaboration between groups and institutions engaged in conducting trials. The HNSC's membership comprises NCTN group representatives, community oncologists, Specialized Programs of Research Excellence (SPORE) representatives, biostatisticians, patient advocates, subject matter experts, and NCI staff.
Co-Chairs
Carole Fakhry, M.D., M.P.H.
Johns Hopkins Medical Institute
Loren K. Mell, M.D.
University of California San Diego
Nabil Saba, M.D., FACP
Emory University School of Medicine
Members
Nishant Agrawal, M.D.
University of Chicago
Scott V. Bratman, M.D., Ph.D.
Princess Margaret Cancer Centre
Barbara Burtness, M.D.
Yale University
Christine Chung, M.D.
H. Lee Moffitt Cancer Center and Research Institute
Joseph N. Contessa, M.D., Ph.D.
Rutgers Cancer Institute of New Jersey
Melissa Lynn Cooke, M.S., CCC-SLP
Head and Neck Cancer Alliance
John Hilton, M.D., FRCPC
The Ottowa Hospital Cancer Center
Alan Loh Ho, M.D., Ph.D.
Memorial Sloan Kettering Cancer Center
Andrew Jonathan Huang, M.D.
Aspirus Cancer Care
Shakun M. Malik, M.D.
National Cancer Institute
Mei-Yin C. Polley, Ph.D.
University of Chicago
Aswanth Reddy, M.D.
Mercy Hospital
Lindsay Anne Renfro, Ph.D., M.S.
University of Southern California
Jolie Ringash, M.D., M.Sc.
The Princess Margaret Cancer Centre
Joseph Salama, M.D.
Duke University Medical Center
Natalie Lea Silver, M.D., M.S.
Cleveland Clinic
Christina Sisti, D.P.S.
Patient Advocate
Heath Skinner, M.D., Ph.D.
UPMC Hillman Cancer Center
Rathan Subramaniam, M.D., Ph.D., M.P.H.
Health New Zealand
Ammar Sukari, M.D.
Karmanos Cancer Institute
Pedro A. Torres-Saavedra, Ph.D.
National Cancer Institute
Bhadrasain Vikram, M.D.
National Cancer Institute
Trisha Michel Wise-Draper, M.D., Ph.D.
University of Cincinnati
Sue S. Yom, M.D., Ph.D.
University of California San Francisco
George Yoo, M.D.
Wayne State University, Karmanos Cancer Institute
NCI CCCT Program Director
Mehrdad Mohseni, M.D.
mehrdad.mohseni@nih.gov